Pantoprazole Sodium Enteric-Coated Capsules (泮托拉唑钠肠溶胶囊)泮托拉唑钠肠溶胶囊

This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。

Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。

生产企业Manufacturer

主要成分Active Ingredients

药物知识说明

泮托拉唑是一种在国家药监局注册认定的药品。该药品含有泮托拉唑-449cb32b等成分。

该药品关联的活性成分包括:泮托拉唑pantoprazole。这些成分信息来自国家药监局数据库。

该药品标注的生产企业为:永信药品工业(昆山)有限公司Chinese legal name: 永信药品工业(昆山有限公司)。

您可以探索含有相同成分的其他药品:泮托拉唑-449cb32b成分药品。

本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。

Medicine Knowledge

pantoprazole is a medicine registered with the national drug regulatory authority. It contains pantoprazole as active ingredient(s).

Active ingredients associated with this product: pantoprazolepantoprazole.

Manufacturers recorded for this product: 永信药品工业(昆山)有限公司Chinese legal name: 永信药品工业(昆山有限公司).

Explore other medicines containing the same ingredient: pantoprazole products.

Source: MedicineGraph authoritative database. Relationships derived from registered product information.

这是什么What is this

  • 通用名/品名Recorded product name: 泮托拉唑钠肠溶胶囊Pantoprazole Sodium Enteric-Coated Capsules (泮托拉唑钠肠溶胶囊)
  • 剂型Dosage form: 胶囊剂Capsules
  • 规格Specification: 40mg(以泮托拉唑计)Recorded Chinese specification: 40mg(以泮托拉唑计)

本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.

主要成分Ingredients

生产企业Manufacturer

  • 永信药品工业(昆山)有限公司Chinese legal name: 永信药品工业(昆山有限公司)

注册信息NMPA approval number

  • 批准文号NMPA approval number: 国药准字H20052585

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.

  • 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
  • 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
  • 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.

本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.

English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.

NMPA approval number

国药准字H20052585

Manufacturer

Chinese legal name: 永信药品工业(昆山)有限公司 (domestically manufactured)

Indications

English translation unavailable. The original Chinese source label remains available below.

Dosage and administration

English translation unavailable. The original Chinese source label remains available below.

Adverse reactions

English translation unavailable. The original Chinese source label remains available below.

Contraindications

English translation unavailable. The original Chinese source label remains available below.

Precautions

English translation unavailable. The original Chinese source label remains available below.

Storage

English translation unavailable. The original Chinese source label remains available below.

Specification

English translation unavailable. The original Chinese source label remains available below.

中文说明书原文Original Chinese source label

批准文号

国药准字H20052585

生产企业

永信药品工业(昆山)有限公司(国产)

适应症

本品适用于活动性消化性溃疡(胃、十二指肠溃疡),反流性食管炎和卓艾氏综合症。

用法用量

1.十二指肠溃疡,胃溃疡和反流性食管炎,每日早晨口服40mg(2粒)。 2.十二指肠溃疡疗程通常为2-4周,胃溃疡和反流性食管炎疗程通常为4-8周。

不良反应

临床应用偶有头晕、失眠、嗜睡、恶心、腹泻和便秘、皮疹、肌肉疼痛等症状。

禁忌

对本品过敏者、哺乳期妇女及妊娠头三个月妇女禁用。

注意事项

1.大剂量使用时可出现心律不齐、转氨酶增高、肾功能改变、粒细胞降低等。
2.本品为肠溶制剂、服用时请勿咀嚼、但可将内容物倒出服用。
3.当怀疑胃溃疡时、应首先排除癌症的可能性、因为本品治疗可减轻其症状、从而延误诊断。
4.肝肾功能不全者慎用、严重肝病时本品清除延缓、应减少用量。

贮藏

遮光,密封,在阴凉干燥处保存。

规格

40mg(以泮托拉唑计)

证据Evidence

  • 批准文号: 国药准字H20052585
  • rights: 本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.